Latest Breaking News On - Raymond debbane - Page 1 : comparemela.com

Lexicon Pharma: Inpefa s Early Clinical Benefits, Rehospitalization Data May Unlock Value

Lexicon Pharma: Inpefa s Early Clinical Benefits, Rehospitalization Data May Unlock Value
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United statesEli lillyCraig granowitzAstrazeneca farxigaEli lilly jardianceRaymond debbaneAmerican heart associationLexicon pharmaceuticals incWw internationalEuropean medicines agencyAmerican college of cardiologyBoehringer ingelheimHeart failure society of americaLexicon pharmaceuticalsHeart failureLexicon pharma

Baystate Wealth Management LLC Invests $28,000 in Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX)

Baystate Wealth Management LLC Invests $28,000 in Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRaymond debbaneLexicon pharmaceuticals trading downNuveen asset managementSecurities exchange commissionNews ratings for lexicon pharmaceuticals dailyTucker asset managementLexicon pharmaceuticals incLexicon pharmaceuticalsBaystate wealth managementExchange commissionProsperity financial group incQuarter for lexicon pharmaceuticalsFree reportFinancial groupAsset management

Prosperity Financial Group Inc Makes New Investment in Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX)

Prosperity Financial Group Inc. acquired a new position in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 26,000 shares of the biopharmaceutical company’s stock, valued at approximately $60,000. Several other institutional […]

Raymond debbaneLexicon pharmaceuticals tradingInsider activity at lexicon pharmaceuticalsExchange commissionSwiss national bankNews ratings for lexicon pharmaceuticals dailyQuarter for lexicon pharmaceuticalsProsperity financial group incLexicon pharmaceuticalsSecurities exchange commissionDimensional fund advisorsLexicon pharmaceuticals incCharles schwab investment management incRenaissance technologiesProsperity financial groupFree report

BVF Inc IL Raises Stake in Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX)

BVF Inc. IL boosted its holdings in shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Free Report) by 23.8% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 19,995,332 shares of the biopharmaceutical company’s stock after buying an additional 3,846,153 shares during the period. Lexicon Pharmaceuticals makes up approximately 1.3% of BVF Inc. IL’s […]

United statesRaymond debbaneBvf incLexicon pharmaceuticals stock performanceQuarter for lexicon pharmaceuticalsHoldings channelLexicon pharmaceuticals profileSecurities exchange commissionLexicon pharmaceuticalsLexicon pharmaceuticals incStifel financial corpNews ratings for lexicon pharmaceuticals dailyFree reportFinancial corpStreet groupRetirement system

Lexicon Pharmaceuticals, Inc (NASDAQ:LXRX) Short Interest Up 12 7% in October

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 21,980,000 shares, a growth of 12.7% from the October 15th total of 19,500,000 shares. Based on an average trading volume of 2,210,000 shares, […]

Raymond debbaneKestra advisory servicesRaymond james associatesNews ratings for lexicon pharmaceuticals dailyBaystate wealth managementSecurities exchange commissionLexicon pharmaceuticalsLexicon pharmaceuticals stock performanceNational associationLexicon pharmaceuticals incGet free reportDirector raymond debbaneExchange commissionMontreal canWealth managementLexicon pharmaceuticals daily